y 27632 has been researched along with Hyperoxia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CM; Chou, HC; Huang, LT; Yeh, TF | 1 |
| Belcastro, R; Ivanovska, J; Jankov, RP; Kantores, C; Lau, M; McNamara, PJ; Tanswell, AK; Xu, EZ; Ziino, AJ | 1 |
2 other study(ies) available for y 27632 and Hyperoxia
| Article | Year |
|---|---|
Rho-kinase inhibitor Y-27632 attenuates pulmonary hypertension in hyperoxia-exposed newborn rats.
Topics: Amides; Animals; Animals, Newborn; Antihypertensive Agents; Blotting, Western; Disease Models, Animal; Female; Hyperoxia; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Pyridines; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; Time Factors | 2013 |
Effects of rho-kinase inhibition on pulmonary hypertension, lung growth, and structure in neonatal rats chronically exposed to hypoxia.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Airway Remodeling; Amides; Animals; Animals, Newborn; Antihypertensive Agents; Becaplermin; Body Weight; Chronic Disease; Disease Models, Animal; DNA Replication; Dose-Response Relationship, Drug; Hyperoxia; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung; Muscle, Smooth, Vascular; Organ Size; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-sis; Pulmonary Artery; Pyridines; Rats; Receptor, Platelet-Derived Growth Factor beta; rho-Associated Kinases; Vascular Resistance | 2010 |